MedTrace Logo

Healthy Volunteer Study Comparing Tablet and Oral Solution Formulations

NCT04814472 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2021-11-10

No results posted yet for this study

Summary

A Two-Part, Open-Label, Crossover, Bioavailability Study Comparing Tablet and Oral Solution Formulations of BLD-0409 in Healthy Volunteers

Conditions

  • Relative Bioavailability

Interventions

DRUG

BLD-0409

Randomized to active product.

Sponsors & Collaborators

  • Blade Therapeutics

    lead INDUSTRY

Principal Investigators

  • Christopher Argent, MD · Scientia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-16
Primary Completion
2021-08-17
Completion
2021-11-03

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04814472 on ClinicalTrials.gov